IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype

Bladder cancer is one of the most common malignancies of urinary tract. The current study aimed to investigate the role of insulin-like growth factor II messenger RNA binding protein 3 (IMP3) expression in the prognostic evaluation of non-muscle- invasive urothelial carcinoma of the bladder. Immunoh...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Feiya, Zhou, Qiang, Meng, Lingquan, Xing, Nianzeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635297/
https://www.ncbi.nlm.nih.gov/pubmed/31277094
http://dx.doi.org/10.1097/MD.0000000000016009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635297/
https://www.ncbi.nlm.nih.gov/pubmed/31277094
http://dx.doi.org/10.1097/MD.0000000000016009

Ejemplares similares